SYM FINANCIAL Corp Buys New Stake in Centene Co. (NYSE:CNC)

SYM FINANCIAL Corp acquired a new stake in Centene Co. (NYSE:CNC) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 3,284 shares of the company’s stock, valued at approximately $247,000.

Other institutional investors have also modified their holdings of the company. WR Wealth Planners LLC grew its position in shares of Centene by 41.4% during the second quarter. WR Wealth Planners LLC now owns 468 shares of the company’s stock worth $31,000 after acquiring an additional 137 shares during the last quarter. Whittier Trust Co. increased its stake in Centene by 10.0% in the second quarter. Whittier Trust Co. now owns 1,562 shares of the company’s stock valued at $104,000 after purchasing an additional 142 shares during the period. Mount Yale Investment Advisors LLC boosted its stake in shares of Centene by 2.1% during the third quarter. Mount Yale Investment Advisors LLC now owns 8,082 shares of the company’s stock worth $608,000 after buying an additional 167 shares during the period. Meridian Management Co. grew its holdings in shares of Centene by 0.3% during the second quarter. Meridian Management Co. now owns 64,721 shares of the company’s stock worth $4,291,000 after buying an additional 189 shares during the last quarter. Finally, E Fund Management Co. Ltd. raised its stake in Centene by 6.4% during the 2nd quarter. E Fund Management Co. Ltd. now owns 3,309 shares of the company’s stock valued at $219,000 after acquiring an additional 199 shares during the last quarter. Institutional investors and hedge funds own 93.63% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on the stock. Robert W. Baird lowered their target price on shares of Centene from $83.00 to $66.00 and set a “neutral” rating on the stock in a research report on Friday, October 25th. Sanford C. Bernstein lowered their target price on shares of Centene from $96.00 to $88.00 and set an “outperform” rating for the company in a report on Wednesday, October 30th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $90.00 target price on shares of Centene in a research report on Tuesday, October 1st. StockNews.com downgraded Centene from a “strong-buy” rating to a “buy” rating in a research report on Monday, October 28th. Finally, Barclays reduced their price objective on Centene from $97.00 to $91.00 and set an “overweight” rating on the stock in a research note on Tuesday, October 29th. Seven research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $83.92.

Centene Trading Down 3.0 %

Shares of NYSE CNC opened at $57.95 on Friday. The business has a 50 day simple moving average of $63.91 and a 200 day simple moving average of $69.42. Centene Co. has a 52 week low of $57.20 and a 52 week high of $81.42. The stock has a market cap of $29.26 billion, a price-to-earnings ratio of 10.06, a PEG ratio of 0.82 and a beta of 0.46. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.10 and a current ratio of 1.10.

Insider Transactions at Centene

In other news, CEO Sarah London bought 4,117 shares of the business’s stock in a transaction dated Friday, November 8th. The stock was bought at an average price of $60.80 per share, for a total transaction of $250,313.60. Following the completion of the purchase, the chief executive officer now owns 667,229 shares of the company’s stock, valued at approximately $40,567,523.20. The trade was a 0.62 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Andrew Lynn Asher acquired 17,200 shares of the business’s stock in a transaction on Wednesday, November 13th. The stock was acquired at an average price of $58.14 per share, with a total value of $1,000,008.00. Following the transaction, the chief financial officer now owns 486,847 shares in the company, valued at approximately $28,305,284.58. The trade was a 3.66 % increase in their position. The disclosure for this purchase can be found here. 0.33% of the stock is currently owned by corporate insiders.

Centene Company Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.